Biotech8 months ago
Boehringer Ingelheim Invests 62 Million Euros in R&D&i in Spain, 36% More
Boehringer Ingelheim Spain significantly increased its R&D&I investment to 62.7 million euros, up 36% from the previous year, representing 11.5% of net sales. Their human health...